1. Vaccine in National Immunization Programme Update
January 2018

2. Countries using IPV vaccine to date
This information is available from the
IPV Introduction, OPV Withdrawal and Routine Immunization Strengthening: activated_polio_vaccine/en/
(click on the hyperlink to access the website – on its right hand column a slide set presentation in downloadable)

3. Countries with Hib vaccine in the national immunization programme;
Introduced* to date
Afghanistan, Albania, Algeria, Andorra, Angola, Antigua and Barbuda, Argentina, Armenia, Australia, Austria, Azerbaijan, Bahamas, Bahrain, Bangladesh, Barbados, Belarus, Belgium, Belize, Benin, Bhutan, Bolivia, Bosnia and Herzegovina, Botswana, Brazil, Brunei Darussalam, Bulgaria, Burkina Faso, Burundi, Cabo Verde, Cambodia, Cameroon, Canada, Central African Republic, Chad, Chile, Colombia, Comoros, Congo, Cook Islands, Costa Rica, Côte d'Ivoire, Croatia, Cuba, Cyprus, Czech Republic, Democratic People's Republic of Korea, Democratic Republic of the Congo, Denmark, Djibouti, Dominica, Dominican Republic, Ecuador, Egypt, El Salvador, Equatorial Guinea, Eritrea, Estonia, Ethiopia, Fiji, Finland, France, Gabon, Gambia, Georgia, Germany, Ghana, Greece, Grenada, Guatemala, Guinea, Guinea-Bissau, Guyana, Haiti, Honduras, Hungary, Iceland, India, Indonesia, Iran (Islamic Republic of), Iraq, Ireland, Israel, Italy, Jamaica, Japan, Jordan, Kazakhstan, Kenya, Kiribati, Kuwait, Kyrgyzstan, Lao People's Democratic Republic, Latvia, Lebanon, Lesotho, Liberia, Libya, Lithuania, Luxembourg, Madagascar, Malawi, Malaysia, Maldives, Mali, Malta, Marshall Islands, Mauritania, Mauritius, Mexico, Micronesia (Federated States of ), Monaco, Mongolia, Montenegro, Morocco, Mozambique, Myanmar, Namibia, Nauru, Nepal, Netherlands, New Zealand, Nicaragua, Niger, Nigeria, Niue, Norway, Oman, Pakistan, Palau, Panama, Papua New Guinea, Paraguay, Peru, Philippines, Poland, Portugal, Qatar, Republic of Korea, Republic of Moldova, Romania, Russian Federation, Rwanda, Saint Kitts and Nevis, Saint Lucia, Saint Vincent and the Grenadines, Samoa, San Marino, Sao Tome and Principe, Saudi Arabia, Senegal, Serbia, Seychelles, Sierra Leone, Singapore, Slovakia, Slovenia, Solomon Islands, Somalia, South Africa, South Sudan, Spain, Sri Lanka, Sudan, Suriname, Swaziland, Sweden, Switzerland, Syrian Arab Republic, Tajikistan, The former Yugoslav Republic of Macedonia, Timor-Leste, Togo, Tonga, Trinidad and Tobago, Tunisia, Turkey, Turkmenistan, Tuvalu, Uganda, Ukraine, United Arab Emirates, United Kingdom, United Republic of Tanzania, United States of America, Uruguay, Uzbekistan, Vanuatu, Venezuela, Viet Nam, Yemen, Zambia, Zimbabwe
Partial introductions in Belarus
No planned introduction
Not Available, Not Introduced/No Plans
China, Russian Federation, Thailand
Introduced* to date
(191 countries or 98%)
Not Available, Not Introduced/No Plans
* Includes partial introduction
(3 countries or 2%)
Not applicable
The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps repre8ent approximate border lines for which there may not yet be full agreement. ©WHO All rights reserved.
Data source: WHO/IVB Database, as of 26 January 2018
Map production Immunization Vaccines and Biologicals (IVB),
World Health Organization

4. Countries with Pneumococcal Conjugate vaccine in the national immunization programme; and planned introductions in 2018
Introduced* to date
Afghanistan, Albania, Algeria, Andorra, Angola, Argentina, Armenia, Australia, Austria, Azerbaijan, Bahamas, Bahrain, Bangladesh, Barbados, Belgium, Benin, Bolivia, Botswana, Brazil, Bulgaria, Burkina Faso, Burundi, Cambodia, Cameroon, Canada, Central African Republic, Chile, Colombia, Congo, Costa Rica, Côte d'Ivoire, Cyprus, Democratic Republic of the Congo, Denmark, Djibouti, Dominican Republic, Ecuador, El Salvador, Eritrea, Ethiopia, Fiji, Finland, France, Gambia, Georgia, Germany, Ghana, Greece, Guatemala, Guinea-Bissau, Guyana, Honduras, Hungary, Iceland, India, Iraq, Ireland, Israel, Italy, Japan, Kazakhstan, Kenya, Kiribati, Kuwait, Kyrgyzstan, Lao People's Democratic Republic, Latvia, Lebanon, Lesotho, Liberia, Libya, Lithuania, Luxembourg, Madagascar, Malawi, Mali, Marshall Islands, Mauritania, Mauritius, Mexico, Micronesia (Federated States of ), Monaco, Mongolia, Morocco, Mozambique, Myanmar, Namibia, Nepal, Netherlands, New Zealand, Nicaragua, Niger, Nigeria, Niue, Norway, Oman, Pakistan, Palau, Panama, Papua New Guinea, Paraguay, Peru, Philippines, Portugal, Qatar, Republic of Korea, Republic of Moldova, Russian Federation, Rwanda, San Marino, Sao Tome and Principe, Saudi Arabia, Senegal, Sierra Leone, Singapore, Slovakia, Slovenia, Solomon Islands, South Africa, Sudan, Swaziland, Sweden, Switzerland, Togo, Trinidad and Tobago, Turkey, Uganda, United Arab Emirates, United Kingdom, United Republic of Tanzania, United States of America, Uruguay, Uzbekistan, Venezuela, Yemen, Zambia, Zimbabwe
Partial introductions in India, Mongolia, Nigeria and the Philippines
Planned introductions in 2018 in Grenada, Haiti, Indonesia, Seychelles
Not Available, Not Introduced/No Plans
Antigua and Barbuda, Belarus, Belize, Bhutan, Bosnia and Herzegovina, Brunei Darussalam, Cabo Verde, Chad, China, Comoros, Cook Islands, Croatia, Cuba, Czech Republic, Democratic People's Republic of Korea, Dominica, Egypt, Equatorial Guinea, Estonia, Gabon, Guinea, Iran (Islamic Republic of), Jamaica, Jordan, Malaysia, Maldives, Malta, Montenegro, Nauru, Poland, Romania, Saint Kitts and Nevis, Saint Lucia, Saint Vincent and the Grenadines, Samoa, Serbia, Somalia, South Sudan, Spain, Sri Lanka, Suriname, Syrian Arab Republic, Tajikistan, Thailand, The former Yugoslav Republic of Macedonia, Timor-Leste, Tonga, Tunisia, Turkmenistan, Tuvalu, Ukraine, Vanuatu, Viet Nam
Introduced* to date
(137 countries or 70.6%)
Planned introductions in 2018
(4 countries or 2.1%)
Not Available, Not Introduced/No Plans
* Includes partial introduction
(53 countries or 27.3%)
Not applicable
The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. ©WHO All rights reserved.
Data source: WHO/IVB Database, as of 26 January 2018
Map production Immunization Vaccines and Biologicals (IVB),
World Health Organization

5. Countries with Rotavirus vaccine in the national immunization programme; and planned introductions in 2018
Introduced* to date
Angola, Argentina, Armenia, Australia, Austria, Bahrain, Belgium, Bolivia, Botswana, Brazil, Burkina Faso, Burundi, Cameroon, Canada, Colombia, Congo, Côte d'Ivoire, Djibouti, Dominican Republic, Ecuador, El Salvador, Eritrea, Estonia, Ethiopia, Fiji, Finland, Gambia, Georgia, Germany, Ghana, Greece, Guatemala, Guinea-Bissau, Guyana, Haiti, Honduras, India, Iraq, Ireland, Israel, Italy, Jordan, Kenya, Kiribati, Latvia, Lesotho, Liberia, Libya, Luxembourg, Madagascar, Malawi, Mali, Marshall Islands, Mauritania, Mauritius, Mexico, Micronesia (Federated States of ), Morocco, Mozambique, Namibia, New Zealand, Nicaragua, Niger, Norway, Pakistan, Palau, Panama, Paraguay, Peru, Qatar, Republic of Moldova, Russian Federation, Rwanda, Sao Tome and Principe, Saudi Arabia, Senegal, Seychelles, Sierra Leone, South Africa, Sudan, Swaziland, Sweden, Tajikistan, Togo, United Arab Emirates, United Kingdom, United Republic of Tanzania, United States of America, Uzbekistan, Venezuela, Yemen, Zambia, Zimbabwe
Partial introduction in Canada, India, Italy, Pakistan, Russian Federation and Sweden.
Planned introductions in 2018 in Afghanistan, Benin, Central African Republic, Democratic Republic of the Congo, Gabon, Kyrgyzstan, Nepal, Nigeria, Uganda
Not Available, Not Introduced/No Plans
Albania, Algeria, Andorra, Antigua and Barbuda, Azerbaijan, Bahamas, Bangladesh, Barbados, Belarus, Belize, Bhutan, Bosnia and Herzegovina, Brunei Darussalam, Bulgaria, Cabo Verde, Cambodia, Chad, Chile, China, Comoros, Cook Islands, Costa Rica, Croatia, Cuba, Cyprus, Czech Republic, Democratic People's Republic of Korea, Denmark, Dominica, Egypt, Equatorial Guinea, France, Grenada, Guinea, Hungary, Iceland, Indonesia, Iran (Islamic Republic of), Jamaica, Japan, Kazakhstan, Kuwait, Lao People's Democratic Republic, Lebanon, Lithuania, Malaysia, Maldives, Malta, Monaco, Mongolia, Montenegro, Myanmar, Nauru, Netherlands, Niue, Oman, Papua New Guinea, Philippines, Poland, Portugal, Republic of Korea, Romania, Saint Kitts and Nevis, Saint Lucia, Saint Vincent and the Grenadines, Samoa, San Marino, Serbia, Singapore, Slovakia, Slovenia, Solomon Islands, Somalia, South Sudan, Spain, Sri Lanka, Suriname, Switzerland, Syrian Arab Republic, Thailand, The former Yugoslav Republic of Macedonia, Timor-Leste, Tonga, Trinidad and Tobago, Tunisia, Turkey, Turkmenistan, Tuvalu, Ukraine, Uruguay, Vanuatu, Viet Nam
Introduced* to date
(93 countries or 48%)
Planned introductions in 2018
(9 countries or 5%)
Not Available, Not Introduced/No Plans
* Includes partial introduction
(92 countries or 47%)
Not applicable
The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. ©WHO All rights reserved.
Data source: WHO/IVB Database, as of 26 January 2018
Map production Immunization Vaccines and Biologicals (IVB),
World Health Organization

6. Countries with HPV vaccine in the national immunization programme
Introduced* to date
Andorra, Argentina, Australia, Austria, Bahamas, Barbados, Belgium, Belize, Bhutan, Bolivia, Botswana, Brazil, Brunei Darussalam, Canada, Chile, Colombia, Cook Islands, Croatia, Cyprus, Czech Republic, Denmark, Ecuador, Estonia, Fiji, Finland, France, Germany, Greece, Guyana, Honduras, Hungary, Iceland, Ireland, Israel, Italy, Jamaica, Japan, Latvia, Lesotho, Libya, Lithuania, Luxembourg, Malaysia, Malta, Marshall Islands, Mexico, Micronesia (Federated States of ), Monaco, Netherlands, New Zealand, Norway, Palau, Panama, Paraguay, Peru, Philippines, Portugal, Republic of Korea, Russian Federation, Rwanda, Saint Vincent and the Grenadines, San Marino, Seychelles, Singapore, Slovenia, South Africa, Spain, Sri Lanka, Suriname, Sweden, Switzerland, Thailand, The former Yugoslav Republic of Macedonia, Trinidad and Tobago, Turkmenistan, Uganda, United Kingdom, United States of America, Uruguay
Not Available,
Not Introduced/No Plans
Afghanistan, Albania, Algeria, Angola, Antigua and Barbuda, Armenia, Azerbaijan, Bahrain, Bangladesh, Belarus, Benin, Bosnia and Herzegovina, Bulgaria, Burkina Faso, Burundi, Cabo Verde, Cambodia, Cameroon, Central African Republic, Chad, China, Comoros, Congo, Costa Rica, Côte d'Ivoire, Cuba, Democratic People's Republic of Korea, Democratic Republic of the Congo, Djibouti, Dominica, Dominican Republic, Egypt, El Salvador, Equatorial Guinea, Eritrea, Ethiopia, Gabon, Gambia, Georgia, Ghana, Grenada, Guatemala, Guinea, Guinea-Bissau, Haiti, India, Indonesia, Iran (Islamic Republic of), Iraq, Jordan, Kazakhstan, Kenya, Kiribati, Kuwait, Kyrgyzstan, Lao People's Democratic Republic, Lebanon, Liberia, Madagascar, Malawi, Maldives, Mali, Mauritania, Mauritius, Mongolia, Montenegro, Morocco, Mozambique, Myanmar, Namibia, Nauru, Nepal, Nicaragua, Niger, Nigeria, Niue, Oman, Pakistan, Papua New Guinea, Poland, Qatar, Republic of Moldova, Romania, Saint Kitts and Nevis, Saint Lucia, Samoa, Sao Tome and Principe, Saudi Arabia, Senegal, Serbia, Sierra Leone, Slovakia, Solomon Islands, Somalia, South Sudan, Sudan, Swaziland, Syrian Arab Republic, Tajikistan, Timor-Leste, Togo, Tonga, Tunisia, Turkey, Tuvalu, Ukraine, United Arab Emirates, United Republic of Tanzania, Uzbekistan, Vanuatu, Venezuela, Viet Nam, Yemen, Zambia, Zimbabwe
Introduced* to date
(79 countries or 40.7%)
Not Available,
Not Introduced/No Plans
(115 countries or 59.3%)
* Includes partial introduction
Not applicable
The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. ©WHO All rights reserved.
Data source: WHO/IVB Database, as of 26 January 2018
Map production Immunization Vaccines and Biologicals (IVB),
World Health Organization

7. Countries using Measles Second Dose vaccine to date; and planned introductions in 2018
Introduced to date
Afghanistan, Albania, Algeria, Andorra, Angola, Antigua and Barbuda, Argentina, Armenia, Australia, Austria, Azerbaijan, Bahamas, Bahrain, Bangladesh, Barbados, Belarus, Belgium, Belize, Bhutan, Bosnia and Herzegovina, Botswana, Brazil, Brunei Darussalam, Bulgaria, Burkina Faso, Burundi, Cabo Verde, Cambodia, Canada, Chile, China, Colombia, Cook Islands, Costa Rica, Croatia, Cuba, Cyprus, Czech Republic, Democratic People's Republic of Korea, Denmark, Djibouti, Dominica, Ecuador, Egypt, El Salvador, Eritrea, Estonia, Fiji, Finland, France, Gambia, Georgia, Germany, Ghana, Greece, Grenada, Guatemala, Guyana, Haiti, Hungary, Iceland, India, Indonesia, Iran (Islamic Republic of), Iraq, Ireland, Israel, Italy, Jamaica, Japan, Jordan, Kazakhstan, Kenya, Kiribati, Kuwait, Kyrgyzstan, Lao People's Democratic Republic, Latvia, Lebanon, Lesotho, Libya, Lithuania, Luxembourg, Malawi, Malaysia, Maldives, Malta, Marshall Islands, Mauritius, Mexico, Micronesia (Federated States of ), Monaco, Mongolia, Montenegro, Morocco, Mozambique, Myanmar, Nauru, Nepal, Netherlands, New Zealand, Nicaragua, Niger, Niue, Norway, Oman, Pakistan, Palau, Panama, Papua New Guinea, Paraguay, Peru, Philippines, Poland, Portugal, Qatar, Republic of Korea, Republic of Moldova, Romania, Russian Federation, Rwanda, Saint Kitts and Nevis, Saint Lucia, Saint Vincent and the Grenadines, Samoa, San Marino, Sao Tome and Principe, Saudi Arabia, Senegal, Serbia, Seychelles, Sierra Leone, Singapore, Slovakia, Slovenia, South Africa, Spain, Sri Lanka, Sudan, Suriname, Swaziland, Sweden, Switzerland, Syrian Arab Republic, Tajikistan, Thailand, The former Yugoslav Republic of Macedonia, Timor-Leste, Tonga, Trinidad and Tobago, Tunisia, Turkey, Turkmenistan, Tuvalu, Ukraine, United Arab Emirates, United Kingdom, United Republic of Tanzania, United States of America, Uruguay, Uzbekistan, Venezuela, Viet Nam, Yemen, Zambia, Zimbabwe
Planned introductions in 2018 Cameroon, Ethiopia, Solomon Islands, Uganda
Not Available, Not Introduced/No Plans
Benin, Bolivia, Central African Republic, Chad, Comoros, Congo, Côte d'Ivoire, Democratic Republic of the Congo, Dominican Republic, Equatorial Guinea, Gabon, Guinea, Guinea-Bissau, Honduras, Liberia, Madagascar, Mali, Mauritania, Namibia, Nigeria, Somalia, South Sudan, Togo, Vanuatu
Introduced to date
(166 countries or 86%)
Planned introductions in 2018
(4 countries or 2%)
Not Available, Not Introduced/No Plans
(24 countries or 12%)
Not applicable
The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. ©WHO All rights reserved.
Data source: WHO/IVB Database, as of 26 January 2018
Map production Immunization Vaccines and Biologicals (IVB),
World Health Organization

8. Countries with Rubella vaccine in the national immunization programme; and planned introductions in 2018
Introduced to date
Albania, Algeria, Andorra, Antigua and Barbuda, Argentina, Armenia, Australia, Austria, Azerbaijan, Bahamas, Bahrain, Bangladesh, Barbados, Belarus, Belgium, Belize, Bhutan, Bolivia, Bosnia and Herzegovina, Botswana, Brazil, Brunei Darussalam, Bulgaria, Burkina Faso, Burundi, Cabo Verde, Cambodia, Cameroon, Canada, Chile, China, Colombia, Cook Islands, Costa Rica, Croatia, Cuba, Cyprus, Czech Republic, Denmark, Dominica, Dominican Republic, Ecuador, Egypt, El Salvador, Estonia, Fiji, Finland, France, Gambia, Georgia, Germany, Ghana, Greece, Grenada, Guatemala, Guyana, Haiti, Honduras, Hungary, Iceland, India, Indonesia, Iran (Islamic Republic of), Iraq, Ireland, Israel, Italy, Jamaica, Japan, Jordan, Kazakhstan, Kenya, Kiribati, Kuwait, Kyrgyzstan, Lao People's Democratic Republic, Latvia, Lebanon, Lesotho, Libya, Lithuania, Luxembourg, Malaysia, Maldives, Malta, Marshall Islands, Mauritius, Mexico, Micronesia (Federated States of ), Monaco, Mongolia, Montenegro, Morocco, Myanmar, Namibia, Nauru, Nepal, Netherlands, New Zealand, Nicaragua, Niue, Norway, Oman, Palau, Panama, Papua New Guinea, Paraguay, Peru, Philippines, Poland, Portugal, Qatar, Republic of Korea, Republic of Moldova, Romania, Russian Federation, Rwanda, Saint Kitts and Nevis, Saint Lucia, Saint Vincent and the Grenadines, Samoa, San Marino, Sao Tome and Principe, Saudi Arabia, Senegal, Serbia, Seychelles, Singapore, Slovakia, Slovenia, Solomon Islands, Spain, Sri Lanka, Suriname, Swaziland, Sweden, Switzerland, Syrian Arab Republic, Tajikistan, Thailand, The former Yugoslav Republic of Macedonia, Timor-Leste, Tonga, Trinidad and Tobago, Tunisia, Turkey, Turkmenistan, Tuvalu, Ukraine, United Arab Emirates, United Kingdom, United Republic of Tanzania, United States of America, Uruguay, Uzbekistan, Vanuatu, Venezuela, Viet Nam, Yemen, Zambia, Zimbabwe
Partial introductions in India, Indonesia and Lesotho
Planned introductions in 2018 Afghanistan, Angola, Benin, Eritrea, Malawi, Mozambique, Sierra Leone, Togo
Not Available, Not Introduced/No Plans
Central African Republic, Chad, Comoros, Congo, Côte d'Ivoire, Democratic People's Republic of Korea, Democratic Republic of the Congo, Djibouti, Equatorial Guinea, Ethiopia, Gabon, Guinea, Guinea-Bissau, Liberia, Madagascar, Mali, Mauritania, Niger, Nigeria, Pakistan, Somalia, South Africa, South Sudan, Sudan, Uganda
Introduced* to date
(161 countries or 83%)
Planned introductions in 2018
(8 countries or 4%)
Not Available, Not Introduced/No Plans
* Includes partial introduction
(25 countries or 13%)
Not applicable
The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. ©WHO All rights reserved.
Data source: WHO/IVB Database, as of 26 January 2018
Map production Immunization Vaccines and Biologicals (IVB),
World Health Organization

9. Hepatitis B Birth dose (HepB-BD) vaccination strategies by country, updated as of January 2018
HepB-BD introduced to date:
Afghanistan Albania Algeria Andorra Angola Argentina Armenia Australia Azerbaijan Bahrain Belarus Bhutan Bosnia and Herzegovina Botswana Brazil Brunei Darussalam Bulgaria Cambodia Cabo Verde China Colombia Cook Islands Costa Rica Cuba Democratic People’s Republic of Korea (the) Djibouti Dominican Republic (the) Ecuador Egypt El Salvador Estonia Fiji Gambia (the) Georgia Guatemala Honduras India Indonesia Iran (Islamic Republic of) Iraq Israel Kazakhstan Kiribati Kuwait Kyrgyzstan Lao People’s Democratic Republic (the) Lebanon Libya Lithuania Malaysia Maldives Marshall Islands (the) Mauritania Mexico Micronesia (Federated States of) Mongolia Morocco Myanmar Namibia Nauru Nigeria Niue Oman Palau Panama Papua New Guinea Peru Philippines (the) Poland Portugal Qatar Republic of Korea (the) Republic of Moldova (the) Romania Russian Federation (the) Saint Kitts and Nevis Samoa Saudi Arabia Senegal Serbia Singapore Solomon Islands Spain Suriname Syrian Arab Republic (the) Tajikistan Thailand The former Yugoslav Republic of Macedonia Timor-Leste Tonga Tunisia Turkey Turkmenistan Tuvalu Ukraine United Arab Emirates (the) United States of America (the) Uzbekistan Vanuatu Venezuela (Bolivarian Republic of) Viet Nam
HepB-BD only for infants born to HBsAG-positive mothers
Belgium Czech Republic (the) Denmark Dominica France Greece Italy Latvia Luxembourg Monaco Netherlands (the) New Zealand Norway Paraguay Sao Tome and Principe Slovakia Slovenia Sweden Switzerland United Kingdom of Great Britain and Northern Ireland (the)
HepB in schedule but no HepB-BD
Antigua and Barbuda Austria Bahamas (the) Bangladesh Barbados Belize Benin Bolivia (Plurinational State of) Burkina Faso Burundi Cameroon Canada Central African Republic (the) Chad Chile Comoros (the) Congo (the) Côte d'Ivoire Croatia Cyprus Democratic Republic of the Congo (the) Equatorial Guinea Eritrea Ethiopia Gabon Germany Ghana Grenada Guinea Guinea-Bissau Guyana Haiti Ireland Jamaica Japan Jordan Kenya Lesotho Liberia Madagascar Malawi Mali Malta Mauritius Montenegro Mozambique Nepal Nicaragua Niger (the) Pakistan Rwanda Saint Lucia Saint Vincent and the Grenadines San Marino Seychelles Sierra Leone Somalia South Africa South Sudan Sri Lanka Sudan (the) Swaziland Togo Trinidad and Tobago Uganda United Republic of Tanzania (the) Uruguay Yemen Zambia Zimbabwe
HepB given only for risk groups or adolescents
Finland Hungary Iceland
Universal HepB-BD introduced to date
(101 countries or 52%)
HepB-BD only for infants born to mothers with chronic hepatitis B virus infection
(20 countries or 10%)
(70 countries or 36%)
Hepatitis B vaccine in childhood schedule but no universal HepB-BD’
Data source: WHO/IVB Database as at 25/01/2018 and ECDC published data at
194 WHO Member States
Map production Immunization Vaccines and Biologicals (IVB),
World Health Organization
Date of slide: 25 January 2018
HepB only given to adolescents or adults risk groups
(3 countries or 2%)
Not available
The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. ©WHO All rights reserved.
Not applicable

10. Countries with Mumps containing vaccine in the national immunization programme
Introduced* to date
(121 countries or 62%)
Not Available,
Not Introduced/No Plans
(73 countries or 38%)
Not applicable
The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. ©WHO All rights reserved.
Data source: WHO/IVB Database, as of 26 January 2018
Map production Immunization Vaccines and Biologicals (IVB),
World Health Organization

11. Introduction of Varicella Containing Vaccines in National Immunization Programmes, updated as of January 2018
Introduced:Andorra Antigua and Barbuda Argentina Australia Austria Bahamas (the) Bahrain Barbados Brazil Canada Colombia Costa Rica Cyprus Ecuador Germany Greece Israel Italy Japan Latvia Luxembourg Oman Panama Paraguay Qatar Republic of Korea (the) Russian Federation (the) Saudi Arabia Spain Switzerland Turkey United Arab Emirates (the) United States of America (the) Uruguay
Partial introduction in: Antigua and Barbuda and Russian Federation (the)
Introduced for risk groups:
Grenada Guyana Iceland Iran (Islamic Republic of) Kuwait Mexico New Zealand Saint Lucia San Marino Slovenia United Kingdom of Great Britain and Northern Ireland (the)
Introduced* to date
(34 countries or 18%)
Introduced for risk groups only
(11 countries or 6%)
* Includes partial introduction
Not Available,
Not Introduced/No Plans
(149 countries or 77%)
Data source: WHO/IVB Database, as of 22 January 2018 and ECDC website
Map production Immunization Vaccines and Biologicals (IVB),
World Health Organization
Not applicable
The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. ©WHO All rights reserved.

12. Countries and Territories using Yellow fever* vaccine to date
Introduced to date
Angola, Benin, Bolivia (Plurinational State of), Burkina Faso, Cameroon, Central African Republic (the), Chad, Colombia, Congo (the), Côte d'Ivoire, Democratic Republic of the Congo (the), Ecuador, French Guyana, Gabon, Gambia (the), Ghana, Guinea, Guinea-Bissau, Guyana, Kenya, Liberia, Mali, Niger (the), Nigeria, Paraguay, Peru, Senegal, Sierra Leone, Suriname, Togo, Trinidad and Tobago, Venezuela (Bolivarian Republic of)
Sao Tome Y Principe and Seychelles introduced but are not listed as at risk countries.
Introduced in High risk areas
Argentina, Brazil, Panama
At risk but not introduced
Burundi, Equatorial Guinea, Ethiopia, Mauritania, Rwanda, Somalia, South Sudan, Sudan (the), Uganda
Introduced to date
(32 countries or 73%)
Introduced in Hig risk areas
(3 countries or 7%)
At risk but not introduced
(9 countries or 20%)
* WHO considers that 44 countries/Territories are at risk for Yellow fever
Not Available / Not at risk
Not applicable
The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. ©WHO All rights reserved.
Data source: WHO/IVB Database, as of 26 January 2018
Map production Immunization Vaccines and Biologicals (IVB),
World Health Organization

13. Countries and Territories using JE vaccine to date
At risk countries/areas but not introduced
Bangladesh, Bhutan, Brunei Darussalam, Democratic People’s Republic of Korea (the), Indonesia, Myanmar, Pakistan, Philippines (the), Russian Federation and Singapore
Introduced to date
China, Japan, Republic of Korea, Sri Lanka, Thailand
Introduced in the high risk areas: Australia
Introduced in parts of the country
Cambodia, India, Lao People's Democratic Republic, Malaysia, Nepal, Viet Nam
At risk countries/areas but not introduced
(11 countries or 50%)
Introduced to date
(6 countries or 27%)
Introduced in parts of the country
(5 countries or 23%)
Not applicable
Data source: WHO/IVB Database, as of 26 January 2018
International travel Health Database (
Map production Immunization Vaccines and Biologicals (IVB),
World Health Organization
The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. ©WHO All rights reserved.